Pharma
Intellectual property (IP) protection has long been an essential component of creativity, impacting industries by protecting inventions and technological developments. Traditionally, patent management has been a time-consuming and complex procedure requiring extensive legal knowledge and rigorous attention to detail. However, the use of artificial intelligence (AI) is changing the way patents are drafted, analysed, and managed. Patlytics, an AI-powered patent workflow platform, has emerged as a leader in this transformation. The company recently closed a $14 million Series A funding round led by global venture firm Next47, with participation from existing investors such as Google's AI-focused venture fund Gradient, 8VC, Alumni Ventures, Liquid 2 Ventures, and Myriad Venture Partners. This brings Patlytics’ total funding to $21 million within just nine months.
In 2010, Paul Lee and Arthur Jen became fast friends at the University of Waterloo while both were studying engineering. After graduation, Paul took a deep dive into finance, working in venture capital where he gained a deep understanding of what makes companies thrive—how market leaders emerge, what drives sustainable success, and how innovation can be cultivated within organizations. Meanwhile, Arthur pursued software development, building advanced products and technologies to address real-world customer needs. He was co-founder and CTO of Magic, a crypto wallet-as-a-service company used by major brands like Mattel and Macy’s.
Though their career paths diverged, both Paul and Arthur witnessed firsthand how a successful IP strategy could either fuel or hinder innovation. It was this shared insight, coupled with their passion for building businesses that create lasting value, that led to the creation of Patlytics. Their mission from day one: equip IP professionals with the most powerful tools available to drive innovation and strategic success.
